Sign in Register

Drug Changes

Recent Drug Changes

Review recent approvals, biosimilar updates, dosing changes, indications, pronunciation updates, and more.

Popular
Filter
Indication Added
All recent changes1122 Administration Information Updated493 Biosimilar Added0 Brand Dosing Updated302 Dosage Information Updated492 Generic Dosing Updated312 Indication Added25 Indication Removed7 Interchangeable Added0 Introduction Updated35 New Drug0 Pronunciation Updated18 Reference Drug Added0 Top 200 Entry0 Top 200 Rank Decreased0 Top 200 Rank Increased0 Uses Updated15

Indication Added

25 changes from the current 90-day window.

Indication Added

Pluvicto

Novartis Pharmaceuticals

Indication Added: Metastatic prostate carcinoma.

View drug
Indication Added

Pluvicto

Novartis Pharmaceuticals

Indication Added: Metastatic prostate carcinoma.

View drug
Indication Added

Pluvicto

ADVANCED ACCELE

Indication Added: Metastatic prostate carcinoma.

View drug